微生物学理论在不断完善，相关的技术和应用在不断创新，微生物学的研究领域也在不断扩展，从传统的医疗、制药领域，逐渐拓展到环境、农业、能源等多个领域。

本期刊·见为诸位介绍微生物学领域高质量期刊Critical Reviews in Microbiology。除了对期刊进行详尽的介绍外，还将向您介绍刊内近三年高被引文章，以及近一年高阅读文章：

• 肺脑轴

• 环境相对霉度指数（ERMI）的开发与应用

• 针对铜绿假单胞菌呼吸道感染毒力的新策略

Print ISSN：1040-841X Online ISSN: 1549-7828

• 2023最新影响因子：6.0

• 影响因子最佳分区：Q1

• 2023最新 CiteScore：14.7

• CiteScore最佳分区：Q1

• 年度用量：20.9万次

• 稿件接受率：13%

Critical Reviews in Microbiology 期刊发表与人类和动物相关的所有微生物学领域的研究，包括医学和兽医微生物学、公共卫生和环境微生物学。其中涉及与微生物分子生物学、免疫致病性、生理学、生物化学、结构和流行病学有关的主题。期刊尤其关注细菌、病毒、真菌和寄生虫疾病临床方面的研究。

所有综述需兼具分析性、综合性和均衡性。该刊欢迎自发投稿以及附有摘要的综述主题提议。

该期刊已被SCI, Scopus, BIOBASE, PubMed/MedLine 等知名数据库收录。

影响因子

根据JCR显示，Critical Reviews in Microbiology

2023年影响因子为：6.0

在微生物学领域排名 21/161

CiteScore

根据Scopus显示，Critical Reviews in Microbiology

2023年CiteScore为 14.7

免疫学与微生物学：

微生物学领域排名 15/182

应用微生物学与生物技术领域排名 10/127

中国科学院分区

根据2023年12月27日发布的中国科学院期刊分区表（升级版）显示：

大类及分区：生物学2区

小类及分区：微生物学2区

编辑团队

Critical Reviews in Microbiology 期刊的主编由来自格拉斯哥卡利多尼安大学（Glasgow Caledonian University）健康与生命科学学院的Gordon Ramage教授担任。编辑团队由来自英国、美国等多地的研究人员组成。

主编介绍

Gordon Ramage

Gordon Ramage是格拉斯哥卡利多尼安大学（Glasgow Caledonian University）健康与生命科学学院的感染预防与控制学教授，并共同领导通过预防感染保障健康（SHIP）小组。他的研究重点是生物膜检测和控制。

作者分布

根据JCR显示，近三年在Critical Reviews in Microbiology 发文的国家中，较为活跃的是：

• 中国

• 印度

• 美国

近三年，在 Critical Reviews in Microbiology 发文的全球高校和科研机构中，较为活跃的是：

• 中国科学院

• 巴西圣保罗州立大学

• 新加坡国立大学

近三年高被引文章

肺脑轴

通讯作者：谭宇蓉 中南大学医学微生物学系

文章摘要：

The appreciation of human microbiome is gaining strong grounds in biomedical research. In addition to gut-brain axis, is the lung-brain axis, which is hypothesised to link pulmonary microbes to neurodegenerative disorders and behavioural changes. There is a need for analysis based on emerging studies to map out the prospects for lung-brain axis. In this review, relevant English literature and researches in the field of ‘lung-brain axis’ is reported. We recommend all the highlighted prospective studies to be integrated with an interdisciplinary approach. This might require conceptual research approaches based on physiology and pathophysiology. Multimodal aspects should include experimental animal units, while exploring the research gaps and making reference to the already existing human data. The overall microbiome medicine is gaining more ground. Aetiological paths and experimental recommendations as per prospective studies in this review will be an important guideline to develop effective treatments for any lung induced neurodegenerative diseases. An in-depth knowledge of the bi-directional communication between host and microbiome in the lung could help treatment to respiratory infections, alleviate stress, anxiety and enhanced neurological effects. The timely prevention and treatment of neurodegenerative diseases requires paradigm shift of the aetiology and more innovative experimentation.

近一年高阅读量文章

环境相对霉度指数（ERMI）的开发与应用

作者：Stephen J. Vesper

Figure 1. The Environmental Relative Moldiness Index scale.

文章摘要：

The prevalence of asthma in the United States (U.S.) has doubled since 1970, coinciding with the increased use of gypsum-drywall in home construction. Mold growth is promoted when gypsum-drywall gets wet. Since asthma is linked to mold exposures, accurate quantification of mold contamination in homes is critical. Therefore, qPCR assays were created and then used to quantify 36 common molds in dust collected in representative U.S. homes during the first American Health Homes Survey (AHHS). The concentrations of the 36 molds, i.e. 26 water-damage molds (Group 1) and 10 outside molds (Group 2), were used in the formulation of a home’s Environmental Relative Moldiness Index (ERMI) value. The ERMI values for each of the AHHS homes were assembled from lowest to highest to create the ERMI scale, which ranges from −10 to 20. Subsequent epidemiological studies consistently demonstrated that higher ERMI values were linked to asthma development, reduced lung capacity or occupant asthma. Reducing mold exposures by remediation or with HEPA filtration resulted in a reduced prevalence of asthma and improvements in respiratory health. The ERMI scale has also been successfully applied in evaluating mold concentrations in schools and large buildings and appears to have applications outside the U.S.

针对铜绿假单胞菌呼吸道感染毒力的新策略

作者：Tegan M. Hibbert et al.

Figure 1. The virulence factors of P. aeruginosa (red).

文章摘要：

Pseudomonas aeruginosa is an opportunistic pathogen that is responsible for infections in people living with chronic respiratory conditions, such as cystic fibrosis (CF) and non-CF bronchiectasis (NCFB). Traditionally, in people with chronic respiratory disorders, P. aeruginosa infection has been managed with a combination of inhaled and intravenous antibiotic therapies. However, due in part to the prolonged use of antibiotics in these people, the emergence of multi-drug resistant P. aeruginosa strains is a growing concern. The development of anti-virulence therapeutics may provide a new means of treating P. aeruginosa lung infections whilst also combatting the AMR crisis, as these agents are presumed to exert reduced pressure for the emergence of drug resistance as compared to antibiotics. However, the pipeline for developing anti-virulence therapeutics is poorly defined, and it is currently unclear as to whether in vivo and in vitro models effectively replicate the complex pulmonary environment sufficiently to enable development and testing of such therapies for future clinical use. Here, we discuss potential targets for P. aeruginosa anti-virulence therapeutics and the effectiveness of the current models used to study them. Focus is given to the difficulty of replicating the virulence gene expression patterns of P. aeruginosa in the CF and NCFB lung under laboratory conditions and to the challenges this poses for anti-virulence therapeutic development.

"Jour - Know"

为帮助更多科研人员选择更加合适的期刊，Taylor & Francis推出专栏——刊·见，该专栏致力于为读者和广大科研人员带来Taylor & Francis旗下期刊的详细解读，从期刊的基本情况、编委阵容、社会影响力到审稿速度、高被引文章等实用信息，专栏将为您带来最详细的介绍，让您更加全面地了解Taylor & Francis旗下优秀的国际期刊，帮助更多中国卓越科研成果顺利在国际期刊上发表。

以上内容可能更新，请以期刊官网主页为准。